Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
EHC Encompass Health
- 115.320
- +1.950+1.72%
Close Apr 28 16:00 ET
- 116.990
- +1.670+1.45%
Post 19:38 ET
11.61BMarket Cap23.83P/E (TTM)
115.930High113.440Low1.23MVolume113.440Open113.370Pre Close140.92MTurnover1.24%Turnover Ratio25.86P/E (Static)100.71MShares115.93052wk High5.38P/B11.45BFloat Cap82.22052wk Low0.66Dividend TTM99.32MShs Float115.930Historical High0.57%Div YieldTTM2.20%Amplitude0.071Historical Low114.720Avg Price1Lot Size
About Encompass Health Company
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Company Profile
SymbolEHC
Company NameEncompass Health
Listing DateSep 24, 1986
Issue Price6.50
Founded1984
CEOMr. Mark J. Tarr
MarketNYSE
Employees40075
Fiscal Year Ends12-31
Address3660 Grandview Parkway, Suite 200
CityBirmingham
ProvinceAlabama
CountryUnited States of America
Zip Code35243
Phone1-205-967-7116
Company Executives
- Name
- Position
- Salary
- Mark J. Tarr
- Director, President and Chief Executive Officer
- 9.30M
- Dr. Elissa Joy Charbonneau
- Chief Medical Officer
- 1.29M
- Douglas E. Coltharp
- Executive Vice President and Chief Financial Officer
- 3.87M
- Andrew L. Price
- Chief Accounting Officer
- 1.07M
- Patrick W. Tuer
- Executive Vice President and Chief Operating Officer
- --
- John Patrick Darby
- Executive Vice President, General Counsel and Secretary
- 2.56M
- Edmund M. Fay
- Senior Vice President and Treasurer
- --
- Greg D. Carmichael
- Chairman of the Board
- 385.68K
- Nancy M. Schlichting
- Independent Director
- 296.49K
- Leslye G. Katz
- Independent Director
- 318.85K
- Joan E. Herman
- Independent Director
- 303.88K
- Terrance Williams
- Independent Director
- 284.28K
- Kevin J. O’Connor
- Independent Director
- 275.64K
- Edward M. Christie, III
- Independent Director
- 272.91K
- Christopher R. Reidy
- Independent Director
- 306.41K
- Dr. Patricia A. Maryland, Ph.
- Independent Director
- 292.55K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now